{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:55:52Z","timestamp":1793836552754,"version":"4.6.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.thromres.2022.12.002","type":"journal-article","created":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T09:26:02Z","timestamp":1671355562000},"page":"20-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Anticoagulant-related nephropathy induced by direct-acting oral anticoagulants: Clinical characteristics, treatments and outcomes"],"prefix":"10.1016","volume":"222","author":[{"given":"Shanshan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehua","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6143-4457","authenticated-orcid":false,"given":"Shengfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.thromres.2022.12.002_bb0005","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.amjmed.2019.02.038","article-title":"Anticoagulation-related nephropathy: the most common diagnosis you've never heard of","volume":"132","author":"Oliver","year":"2019","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.thromres.2022.12.002_bb0010","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/jth.13229","article-title":"Anticoagulation-related nephropathy","volume":"14","author":"Wheeler","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2022.12.002_bb0015","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1053\/j.ajkd.2009.04.024","article-title":"Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases","volume":"54","author":"Brodsky","year":"2009","journal-title":"Am. J. Kidney Dis."},{"issue":"12","key":"10.1016\/j.thromres.2022.12.002_bb0020","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/ndt\/gft380","article-title":"Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats","volume":"29","author":"Ryan","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.thromres.2022.12.002_bb0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ki.2011.44","article-title":"Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate","volume":"80","author":"Brodsky","year":"2011","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.thromres.2022.12.002_bb0030","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jamacardio.2016.1170","article-title":"Efficacy and safety of apixaban compared with warfarin in patients with atrial fibrillation in relation to renal function over time: insights from the ARISTOTLE randomized clinical trial","volume":"1","author":"Hijazi","year":"2016","journal-title":"JAMA Cardiol."},{"issue":"4","key":"10.1016\/j.thromres.2022.12.002_bb0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.23876\/j.krcp.2017.36.4.387","article-title":"Acute kidney injury aggravated by treatment initiation with apixaban: another twist of anticoagulant-related nephropathy","volume":"36","author":"Brodsky","year":"2017","journal-title":"Kidney Res. Clin. Pract."},{"issue":"5","key":"10.1016\/j.thromres.2022.12.002_bb0040","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ckj\/sft076","article-title":"Warfarin-related nephropathy in a patient with mild IgA nephropathy on dabigatran and aspirin","volume":"6","author":"Moeckel","year":"2013","journal-title":"Clin. Kidney J."},{"issue":"2","key":"10.1016\/j.thromres.2022.12.002_bb0045","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/ckj\/sfaa030","article-title":"Idarucizumab for the treatment of dabigatran-related nephropathy","volume":"14","author":"Alsamarrai","year":"2021","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.thromres.2022.12.002_bb0050","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.thromres.2018.07.019","article-title":"Dabigatran-induced nephropathy and its successful treatment with idarucizumab - case report and literature review","volume":"169","author":"Awesat","year":"2018","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.thromres.2022.12.002_bb0055","first-page":"125","article-title":"Dabigatran causing severe acute kidney injury in a patient with liver cirrhosis","volume":"8","author":"Li","year":"2019"},{"key":"10.1016\/j.thromres.2022.12.002_bb0060","first-page":"7381505","article-title":"Anticoagulant related nephropathy induced by dabigatran","volume":"2018","author":"Sharfuddin","year":"2018"},{"key":"10.1016\/j.thromres.2022.12.002_bb0065","first-page":"8952670","article-title":"Acute kidney injury due to anticoagulant-related nephropathy : a suggestion for therapy","volume":"2020","author":"Zeni","year":"2020","journal-title":"Case Rep. Nephrol."},{"issue":"3","key":"10.1016\/j.thromres.2022.12.002_bb0070","first-page":"321","article-title":"Acute kidney injury and undiagnosed immunoglobulin a nephropathy after dabigatran therapy","volume":"31","author":"Jansky","year":"2018","journal-title":"Proc. (Bayl. Univ. Med. Cent.)"},{"issue":"1","key":"10.1016\/j.thromres.2022.12.002_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-227756","article-title":"Rivaroxaban-related acute kidney injury in a patient with IgA vasculitis","volume":"12","author":"Fujino","year":"2019","journal-title":"BMJ Case Rep."},{"issue":"3","key":"10.1016\/j.thromres.2022.12.002_bb0080","first-page":"212","article-title":"Rivaroxaban-related nephropathy","volume":"31","author":"Oliveira","year":"2017","journal-title":"Portuguese Journal of Nephrology & Hypertension"},{"issue":"8","key":"10.1016\/j.thromres.2022.12.002_bb0085","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s11255-017-1527-9","article-title":"Anticoagulant-related nephropathy: a case report and review of the literature of an increasingly recognized entity","volume":"49","author":"Kalaitzidis","year":"2017","journal-title":"Int. Urol. Nephrol."},{"issue":"4","key":"10.1016\/j.thromres.2022.12.002_bb0090","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s13730-019-00410-7","article-title":"Dabigatran-induced anticoagulant-related nephropathy with undiagnosed IgA nephropathy in a patient with normal baseline renal function","volume":"8","author":"Ikeda","year":"2019","journal-title":"CEN Case Rep."},{"issue":"6","key":"10.1016\/j.thromres.2022.12.002_bb0095","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5414\/CN110661","article-title":"Anticoagulant-related nephropathy to edoxaban","volume":"96","author":"Duarte","year":"2021","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.thromres.2022.12.002_bb0100","article-title":"Dabigatran-related nephropathy in a patient with undiagnosed IgA nephropathy","volume":"2015","author":"Escoli","year":"2015","journal-title":"Case Rep. Nephrol."},{"issue":"1","key":"10.1016\/j.thromres.2022.12.002_bb0105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/0886022X.2021.2014338","article-title":"Simultaneous subacute interstitial nephritis and anticoagulant-related nephropathy related to novel oral anticoagulants use","volume":"44","author":"Deng","year":"2022","journal-title":"Ren. Fail."},{"issue":"4","key":"10.1016\/j.thromres.2022.12.002_bb0110","first-page":"796","article-title":"Management of anticoagulant-related nephropathy: a single center experience","volume":"10","author":"Bel\u010di\u010d Miki\u010d","year":"2021"},{"issue":"4","key":"10.1016\/j.thromres.2022.12.002_bb0115","first-page":"301","article-title":"Anticoagulation-related nephropathy for the internist: a concise review","volume":"10","author":"Mezue","year":"2020","journal-title":"Am. J. Cardiovasc. Dis."},{"issue":"3","key":"10.1016\/j.thromres.2022.12.002_bb0120","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/ckj\/sfy133","article-title":"Anticoagulant-related nephropathy: systematic review and meta-analysis","volume":"12","author":"de Aquino Moura","year":"2019","journal-title":"Clin. Kidney J."},{"issue":"2","key":"10.1016\/j.thromres.2022.12.002_bb0125","article-title":"Anticoagulant-related nephropathy: a common, under-diagnosed clinical entity","volume":"14","author":"Afiari","year":"2022","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.thromres.2022.12.002_bb0130","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0006-2952(84)90451-9","article-title":"Hepatic drug metabolism in rats with experimental chronic renal failure","volume":"33","author":"Patterson","year":"1984","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.thromres.2022.12.002_bb0135","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00467-015-3119-1","article-title":"Haematuria as a risk factor for chronic kidney disease progression in glomerular diseases: a review","volume":"31","author":"Moreno","year":"2016","journal-title":"Pediatr. Nephrol. (Berlin, Germany)"},{"issue":"4","key":"10.1016\/j.thromres.2022.12.002_bb0140","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ekir.2022.01.1048","article-title":"IgA nephropathy is the most common underlying disease in patients with anticoagulant-related nephropathy","volume":"7","author":"Trujillo","year":"2022","journal-title":"Kidney Int. Rep."},{"issue":"4","key":"10.1016\/j.thromres.2022.12.002_bb0145","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.krcp.2014.11.001","article-title":"Anticoagulants and acute kidney injury: clinical and pathology considerations","volume":"33","author":"Brodsky","year":"2014","journal-title":"Kidney Res. Clin. Pract."},{"issue":"15","key":"10.1016\/j.thromres.2022.12.002_bb0150","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15343","article-title":"Role of protease-activated receptor-1 (PAR-1) in the glomerular filtration barrier integrity","volume":"10","author":"Medipally","year":"2022","journal-title":"Physiol. Rep."},{"issue":"4","key":"10.1016\/j.thromres.2022.12.002_bb0155","first-page":"169","article-title":"A case of rivaroxaban-associated acute tubulointerstitial nephritis","volume":"75","author":"Monahan","year":"2017","journal-title":"Neth. J. Med."},{"issue":"4","key":"10.1016\/j.thromres.2022.12.002_bb0160","first-page":"173","article-title":"A case of dabigatran-associated acute renal failure","volume":"112","author":"Shafi","year":"2013","journal-title":"WMJ : official publication of the State Medical Society of Wisconsin"},{"key":"10.1016\/j.thromres.2022.12.002_bb0165","first-page":"6940183","article-title":"Acute renal failure in a patient with rivaroxaban-induced hypersensitivity syndrome: a case report with a review of the literature and of pharmacovigilance registries","volume":"2020","author":"Marcelino","year":"2020","journal-title":"Case Rep. Nephrol."},{"issue":"3","key":"10.1016\/j.thromres.2022.12.002_bb0170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/nep.13058","article-title":"A case report of Henoch-Schonlein purpura and IgA nephropathy associated with rivaroxaban","volume":"23","author":"Chung","year":"2018","journal-title":"Nephrology (Carlton, Vic.)"},{"issue":"1","key":"10.1016\/j.thromres.2022.12.002_bb0175","doi-asserted-by":"crossref","first-page":"10858","DOI":"10.1038\/s41598-018-29008-2","article-title":"Renoprotective effects of a factor xa inhibitor: fusion of basic research and a database analysis","volume":"8","author":"Horinouchi","year":"2018","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.thromres.2022.12.002_bb0180","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012195","article-title":"Rivaroxaban, a direct factor xa inhibitor, ameliorates hypertensive renal damage through inhibition of the inflammatory response mediated by protease-activated receptor pathway","volume":"8","author":"Ichikawa","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"9","key":"10.1016\/j.thromres.2022.12.002_bb0185","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.4103\/jfmpc.jfmpc_671_19","article-title":"Warfarin: a double-edged sword","volume":"8","author":"Yadav","year":"2019","journal-title":"J. Family Med. Prim. Care"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822004790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822004790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:49:12Z","timestamp":1758736152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384822004790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":37,"alternative-id":["S0049384822004790"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2022.12.002","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulant-related nephropathy induced by direct-acting oral anticoagulants: Clinical characteristics, treatments and outcomes","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2022.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}